Interestingly, Mettl3-HOE mice displayed resistance to MCD-induced NASH, as revealed by lower serum ALT activity (Fig. 7c), fewer hepatic lipid droplets (Fig. 7d), and lower liver TAG levels (Fig. 7e). Here, METTL3 is linked to metabolic dysfunction-associated steatohepatitis.